This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Essure Insert (Photo: Business Wire)

Stocks in this article: CPTS

Who should be responsible for birth control is an age-old battle of the sexes. One point couples can agree on, however, is that neither wants to have surgery.

Essure Insert (Photo: Business Wire)

Essure Insert (Photo: Business Wire)

Conceptus Inc. (NASDAQ: CPTS), developer of the Essure® procedure, a non-surgical permanent birth control option for women, today announced the launch of a video campaign that uses humor to help illustrate why men are often reluctant to get a vasectomy. The video, which depicts a handful of men watching footage of an actual vasectomy shows that there is an unease about surgery “down there” as well as a clear lack of awareness about the vasectomy procedure itself.

“The men’s reactions in the video didn’t surprise me at all. My patients, and even more so, their husbands, are very reluctant to undergo surgery as a birth control method,” says Dr. Cindy Basinski, OB/GYN. “That’s why Essure is such a great solution for couples whose families are complete. I perform the Essure procedure right in my office in less than 10 minutes, and women are usually back to their normal routine that same day. Everybody is happy that there is a non-surgical, hormone-free option that both husbands and wives can get behind.”

The timing of the video coincides with a seasonal peak in the number of vasectomies performed. The increase in vasectomies is largely due to men using the recovery time from the procedure as an opportunity to take a little time off work and enjoy the college basketball play-offs with a bag of frozen peas on their laps.

The Essure “Vasectomy Reactions” video was designed to create awareness among men and women that there is a permanent birth control method that does not require surgery, burning, general anesthesia, hormones or slowing down to recover. The Essure procedure, FDA approved since 2002, is 99.8% effective, making it the most effective form of permanent birth control on the market 1. During the 10-minute procedure, a physician places a soft, flexible insert into each fallopian tube. Because the inserts are placed through the natural pathways of the vagina and cervix, no incisions are necessary. Over the next three months, the body works with the inserts to form a natural barrier that prevents sperm from reaching the egg.

“We wanted a new way to reach both men and women about the subject of permanent birth control,” says Sam Trujillo, Executive Vice President of Marketing at Conceptus. “By creating this video, we hope to start conversations and inform couples about their birth control options.”

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,672.60 -141.38 -0.79%
S&P 500 2,051.82 -11.33 -0.55%
NASDAQ 4,757.8790 +7.4820 0.16%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs